Histone post-translational modifications to target memory-related diseases
- PMID: 23448462
- DOI: 10.2174/1381612811319280005
Histone post-translational modifications to target memory-related diseases
Abstract
Epigenetic mechanisms, i.e. the control gene of expression without changing DNA sequence, include DNA methylation, histone post-translational modifications (PTMs) and microRNAs (miRNAs). Aberrant epigenetic modifications are associated with several pathological conditions, including brain diseases, resulting from environmental causes, ageing or genetic factors. The role of histone PTMs, including acetylation, phosphorylation, methylation and ubiquitylation, has been demonstrated in learning and memory, both in physiological conditions and in neuropathologies. Abnormalities in these modifications or in the machinery that control them are associated with several neurodegenerative, neuro-developmental and psychiatric diseases. Therefore, these epigenetic marks are promising targets to address memory-related diseases and strong efforts are presently focused on pharmacological and genetic approaches to this field.
Similar articles
-
Targeting histone acetylation for neuroprotection.Curr Pharm Des. 2013;19(28):5017-8. doi: 10.2174/1381612811319280001. Curr Pharm Des. 2013. PMID: 23448467 No abstract available.
-
Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders.Curr Pharm Des. 2013;19(28):5051-64. doi: 10.2174/13816128113199990382. Curr Pharm Des. 2013. PMID: 23448461 Free PMC article. Review.
-
Histone post-translational modifications in Huntington's and Parkinson's diseases.Curr Pharm Des. 2013;19(28):5085-92. doi: 10.2174/13816128113199990355. Curr Pharm Des. 2013. PMID: 23448464 Review.
-
What's wrong with epigenetics in Huntington's disease?Neuropharmacology. 2014 May;80:103-14. doi: 10.1016/j.neuropharm.2013.10.025. Epub 2013 Oct 31. Neuropharmacology. 2014. PMID: 24184315 Review.
-
Targeting histone-modifications in Alzheimer's disease. What is the evidence that this is a promising therapeutic avenue?Neuropharmacology. 2014 May;80:95-102. doi: 10.1016/j.neuropharm.2014.01.038. Epub 2014 Jan 31. Neuropharmacology. 2014. PMID: 24486385 Review.
Cited by
-
Ketogenic diet improves the spatial memory impairment caused by exposure to hypobaric hypoxia through increased acetylation of histones in rats.PLoS One. 2017 Mar 29;12(3):e0174477. doi: 10.1371/journal.pone.0174477. eCollection 2017. PLoS One. 2017. PMID: 28355243 Free PMC article.
-
Long noncoding RNA NEAT1 inhibits the acetylation of PTEN through the miR-524-5p /HDAC1 axis to promote the proliferation and invasion of laryngeal cancer cells.Aging (Albany NY). 2021 Nov 27;13(22):24850-24865. doi: 10.18632/aging.203719. Epub 2021 Nov 27. Aging (Albany NY). 2021. PMID: 34837887 Free PMC article.
-
Histone deacetylase 1 induced by neddylation inhibition contributes to drug resistance in acute myelogenous leukemia.Cell Commun Signal. 2019 Jul 29;17(1):86. doi: 10.1186/s12964-019-0393-8. Cell Commun Signal. 2019. PMID: 31358016 Free PMC article.
-
Accelerated Deficits of Spatial Learning and Memory Resulting From Prenatal Inflammatory Insult Are Correlated With Abnormal Phosphorylation and Methylation of Histone 3 in CD-1 Mice.Front Aging Neurosci. 2019 May 16;11:114. doi: 10.3389/fnagi.2019.00114. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31156421 Free PMC article.
-
HDAC inhibitors as cognitive enhancers in fear, anxiety and trauma therapy: where do we stand?Biochem Soc Trans. 2014 Apr;42(2):569-81. doi: 10.1042/BST20130233. Biochem Soc Trans. 2014. PMID: 24646280 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous